0000000000894722

AUTHOR

J. Engel

showing 21 related works from this author

Search for composite and exotic fermions at LEP 2

1999

A search for unstable heavy fermions with the DELPHI detector at LEP is reported. Sequential and non-canonical leptons, as well as excited leptons and quarks, are considered. The data analysed correspond to an integrated luminosity of about 48~pb$^{-1}$ at an $e^+e^-$ centre-of-mass energy of 183~GeV and about 20~pb$^{-1}$ equally shared between the centre-of-mass energies of 172~GeV and 161~GeV. The search for pair-produced new leptons establishes 95\% confidence level mass limits in the region between 70~GeV/$c^2$ and 90~GeV/$c^2$, depending on the channel. The search for singly produced excited leptons and quarks establishes upper limits on the ratio of the coupling of the excited fermio…

QuarkParticle physicsPhysics and Astronomy (miscellaneous)PAIR PRODUCTIONCHARGED HEAVY-LEPTONSFOS: Physical sciences7. Clean energy01 natural sciencesPartícules (Física nuclear)CROSS-SECTIONSHigh Energy Physics - ExperimentE(+)E(-) COLLISIONSBHABHA SCATTERINGHigh Energy Physics - Experiment (hep-ex)0103 physical sciencesMONTE-CARLO PROGRAM[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]RADIATIVE-CORRECTIONS010306 general physicsNuclear ExperimentEngineering (miscellaneous)PhysicsLuminosity (scattering theory)010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyFermionCoupling (probability)Z0 DECAYSExcited stateHigh Energy Physics::ExperimentFísica nuclearROOT-S=161 GEVEXCITED LEPTONSCHARGED HEAVY-LEPTONS; MONTE-CARLO PROGRAM; EXCITED LEPTONS; E(+)E(-) COLLISIONS; Z0 DECAYS; ROOT-S=161 GEV; RADIATIVE-CORRECTIONS; BHABHA SCATTERING; PAIR PRODUCTION; CROSS-SECTIONSParticle Physics - ExperimentLepton
researchProduct

Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study.

2019

Purpose: With better access to early diagnosis and appropriate treatment, cervical cancer (CC) burden decreased in several European countries. In Eastern European (EE) countries, which accessed European Union in 2004, CC survival was worse than in the rest of Europe. The present study investigates CC survival differences across five European regions, considering stage at diagnosis (local, regional and metastatic), morphology (mainly squamous versus glandular tumours) and patients’ age. Methods: We analysed 101,714 CC women diagnosed in 2000–2007 and followed-up to December 2008. Age-standardised 5-year relative survival (RS) and the excess risks of cancer death in the 5 years after diagnosi…

MorphologyAdultMaleStage at diagnosiSurvivalAdolescentSocio-culturaleUterine Cervical NeoplasmsDiseaseSettore MED/42 - Igiene Generale E Applicata03 medical and health sciences0302 clinical medicineMedicinemedia_common.cataloged_instanceHumansEuropean UnionEuropean unionSurvival ratePopulation-based studymedia_commonAgedRetrospective StudiesCervical cancerAged 80 and overCervical cancer Europe Morphology Population-based study Stage at diagnosis Survival030219 obstetrics & reproductive medicineRelative survivalbusiness.industryAbsolute risk reductionObstetrics and GynecologyRetrospective cohort studyStage at diagnosisGeneral MedicineMiddle Agedmedicine.diseaseEuropeEastern europeanSurvival Rate030220 oncology & carcinogenesisCervical cancerFemalebusinessDemographyArchives of gynecology and obstetricsReferences
researchProduct

A search for $\eta'_c$ production in photon-photon fusion at LEP

1998

A search for the production of the $\eta'_c$ meson, the first radial excitation of the ground state of charmonium $\eta_c$(2980), in the photon-photon fusion reaction at LEP has been performed using the data collected by the DELPHI detector during 1992-1996. No evidence of $\eta'_c$ production is found in the mass region 3520--3800 MeV/c^2. An upper limit for the ratio of the two-photon widths of the $\eta'_c$ and $\eta_c$ is obtained.

Nuclear and High Energy PhysicsParticle physicsPhotonMesonHigh Energy Physics::LatticeWidth ratio01 natural sciencesPartícules (Física nuclear)High Energy Physics - ExperimentNuclear physics0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear fusion010306 general physicsNuclear ExperimentDELPHIPhysicsFusion010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyLARGE ELECTRON POSITRON COLLIDERLarge Electron–Positron ColliderPARTICLE PHYSICS; LARGE ELECTRON POSITRON COLLIDER; DELPHIPARTICLE PHYSICSFísica nuclearHigh Energy Physics::ExperimentGround stateExcitationParticle Physics - Experiment
researchProduct

Measurement of inclusive K*(0)(892), phi(1020) and K-2*(0)(1430) production in hadronic Z decays

1996

The inclusive production of the neutral vector mesons K-*0(892) and phi(1020), and of the tensor meson K-2(*0)(1430), in hadronic decays of the Z has been mea sured by the DELPHI detector at LEP. The average production rates per hadronic Z decay have been determined to be 0.77 +/- 0.08 K-2(*0)(892), 0.104 +/- 0.008 phi(1020) and 0.079 +/- 0.040 K-2(*0)(1430). The ratio of the tensor-to-vector meson production yields, [K-2(*0)(1430)]/[K-*0(892)] = 0.10 +/- 0.05, is smaller than the [f(2)(1270)]/[rho(0)(770)] and [f'(2)(1525)]/[phi(1020)] ratios measured by DELPHI. The production rates and differential cross sections are compared with the predictions of JETSET 7.4 tuned to the DELPHI data and…

Particle physicsMeson productionPhysics and Astronomy (miscellaneous)MesonElectron–positron annihilationHadronVECTORproduction rate01 natural sciencesPartícules (Física nuclear)DELPHI; neutral vector meson; tensor meson; production rateNuclear physics0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]MESON; VECTOR; GEV/Cneutral vector mesonTensorNeutral vector010306 general physicsDetectors de radiacióDELPHIPhysics010308 nuclear & particles physicstensor mesonGEV/CMass spectrumProduction (computer science)MESON
researchProduct

Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study

2015

BACKGROUND: Significant advances in the management of patients with lymphoid and myeloid malignancies entered clinical practice in the early 2000's. The EUROCARE-5 study database provides an opportunity to assess the impact of these changes at the population level by country in Europe. We provide survival estimates for clinically relevant haematological malignancies (HM), using the International Classification of Diseases for Oncology 3, by country, gender and age in Europe. METHODS: We estimated age-standardised relative survival using the complete cohort approach for 625, 000 adult patients diagnosed in 2000-2007 and followed up to 2008. Survival information was provided by 89 participati…

OncologyCancer registry; Europe; Hodgkin lymphoma; Leukaemia; Lymphoma; Multiple myeloma; Non-Hodgkin lymphoma; Relative survivalCancer Researcheducation.field_of_studymedicine.medical_specialtyMyeloidRelative survivalbusiness.industryPopulationFollicular lymphomaPlasma cell neoplasmmedicine.diseaseLymphomaCancer registrymedicine.anatomical_structureOncologyhemic and lymphatic diseasesInternal medicineImmunologyMedicineeducationbusinessInternational Classification of Diseases for OncologyEuropean Journal of Cancer
researchProduct

Update of the search for charginos nearly mass-degenerate with the lightest neutralino

2000

The data collected by DELPHI in 1998 at the centre-of-mass energy of 189 GeV have been used to update the search for charginos nearly mass-degenerate with the lightest supersymmetric particle, which is assumed to be the lightest neutralino. Mass differences below \Delta M = 3 GeV/c^2 are considered. No excess of events with respect to the Standard Model expectation has been observed, and exclusions in the plane of \Delta M versus chargino mass are given. The new \Delta M independent lower limit on the mass of the chargino is 62.4 GeV/c^2 in the higgsino scenario (which includes the gaugino mass unification scenario), if all sfermions are heavier than the lightest chargino. In the approximat…

Nuclear and High Energy PhysicsParticle physicsCOLLISIONSField (physics)LOWEST ORDER CALCULATIONSENERGIESMONTE-CARLO SIMULATIONFOS: Physical sciences2-PHOTON PROCESSES01 natural sciencesLightest Supersymmetric ParticlePartícules (Física nuclear)Standard ModelHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)MONTE-CARLO SIMULATION; LOWEST ORDER CALCULATIONS; RADIATIVE-CORRECTIONS; 2-PHOTON PROCESSES; COLLISIONS; ENERGIES; PROGRAMChargino0103 physical sciencesPROGRAM[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]RADIATIVE-CORRECTIONSHiggsino010306 general physicsNuclear ExperimentDELPHIPhysics010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyGauginoLEPLARGE ELECTRON POSITRON COLLIDERSfermionNeutralinoPARTICLE PHYSICS; LARGE ELECTRON POSITRON COLLIDER; DELPHIPARTICLE PHYSICSFísica nuclearHigh Energy Physics::ExperimentParticle Physics - Experiment
researchProduct

Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999- 2007: Results…

2015

Abstract Background The EUROCARE study collects and analyses survival data from population-based cancer registries (CRs) in Europe in order to provide data on between-country differences in survival and time trends in survival. Methods This study analyses data on liver cancer, gallbladder and extrahepatic biliary tract cancers (“biliary tract cancers”), and pancreatic cancer diagnosed in 2000–2007 from 88 CRs in 29 countries. Relative survival (RS) was estimated overall, by region, sex, age and period of diagnosis using the complete approach. Time trends in 5-year RS over 1999–2007 were also analysed using the period approach. Results The prognosis of the studied cancers was poor. Age-stand…

Cancer Researchmedicine.medical_specialtySurvivalBiliary tract cancer; Cancer registry; Europe; Pancreatic cancer; Primary liver cancer; Survival; Time trends in survival; Oncology; Cancer ResearchPopulationSocio-culturaleTime trends in survivalGastroenterologyInternal medicinePancreatic cancermedicineeducationSurvival analysiseducation.field_of_studyRelative survivalbusiness.industryGallbladderPrimary liver cancerCancerPancreatic cancerCancer registrymedicine.diseaseCancer registryEuropeBiliary tract cancer ; Cancer registry ; Europe ; Pancreatic cancer ; Primary liver cancer ; Survival ; Time trends in survivalmedicine.anatomical_structureOncologyBiliary tract cancerLiver cancerbusiness
researchProduct

The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods

2015

Abstract Background Since 25 years the EUROCARE study monitors the survival of cancer patients in Europe through centralised collection, quality check and statistical analysis of population-based cancer registries (CRs) data. The European population covered by the study increased remarkably in the latest round. The study design and statistical methods were also changed to improve timeliness and comparability of survival estimates. To interpret the EUROCARE-5 results on adult cancer patients better here we assess the impact of these changes on data quality and on survival comparisons. Methods In EUROCARE-5 the survival differences by area were studied applying the complete cohort approach to…

Cancer ResearchSurvivalPopulationSocio-culturalePopulation-based registriesPopulation-based registrieQuality checksCancer; EUROCARE; Europe; Population-based registries; Quality checks; Survival; Oncology; Cancer ResearchMedicineeducationCancereducation.field_of_studyRelative survivalbusiness.industryPopulation sizeComparabilityCancerPercentage pointmedicine.diseaseQuality checkEuropeOncologyData qualityCohortbusinessEUROCARECancer ; EUROCARE ; Europe ; Population-based registries ; Quality checks ; SurvivalDemography
researchProduct

Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study

2021

The outbreak of severe acute respiratory syndromecoronavirus-2, the cause of coronavirus disease 2019 (COVID-19) in December 2019 represented a global emergency accounting for more than 2.5 million deaths worldwide.1 It has had an unprecedented influence on cardiac surgery internationally, resulting in cautious delivery of surgery and restructuring of services.2 Understanding the influence of COVID-19 on patients after cardiac surgery is based on assumptions from other surgical specialties and single-center studies. The COVIDSurg Collaborative conducted a multicenter cohort study, including 1128 patients, across 235 hospitals, from 24 countries demonstrating perioperative COVID-19 infection…

Pulmonary and Respiratory MedicineMale2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)complication.ArticleNOCohort Studiesoutcomes; complications; following cardiac surgery; coronavirus disease 2019Postoperative ComplicationsCardiovascular Diseases; Cohort Studies; Female; Humans; Male; Middle Aged; SARS-CoV-2; COVID-19; Cardiac Surgical Procedures; Postoperative ComplicationsInternal medicineCardiovascular DiseasemedicineCardiac Surgical ProcedureHumansIn patientCardiac Surgical ProceduresLS7_4business.industrySARS-CoV-2COVID-19Middle AgedCardiac surgeryCardiovascular DiseasesoutcomeSurgeryFemaleCohort StudieCardiology and Cardiovascular Medicinebusinesscardiac surgery[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyCohort studyHuman
researchProduct

The rapid atmospheric monitoring system of the Pierre Auger Observatory

2012

The Pierre Auger Observatory is a facility built to detect air showers produced by cosmic rays above 1017 eV. During clear nights with a low illuminated moon fraction, the UV fluorescence light produced by air showers is recorded by optical telescopes at the Observatory. To correct the observations for variations in atmospheric conditions, atmospheric monitoring is performed at regular intervals ranging from several minutes (for cloud identification) to several hours (for aerosol conditions) to several days (for vertical profiles of temperature, pressure, and humidity). In 2009, the monitoring program was upgraded to allow for additional targeted measurements of atmospheric conditions shor…

[PHYS.ASTR.HE]Physics [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]AstronomyFOS: Physical sciencesCosmic rayReal-time monitoring01 natural sciencesLarge detector systems for particle and astroparticle physics Real-time monitoring Control and monitor systems onlineOptical telescopeObservatory0103 physical sciencesSHOWERSLarge detector systems for particle and astroparticle physics; Real-time monitoring; Control and monitor systems onlineFLUORESCENCE010303 astronomy & astrophysicsInstrumentationInstrumentation and Methods for Astrophysics (astro-ph.IM)DETECTORMathematical PhysicsRemote sensingEvent reconstructionPierre Auger ObservatoryHigh Energy Astrophysical Phenomena (astro-ph.HE)010308 nuclear & particles physicsLarge detector systems for particle and astroparticle physicsControl and monitor systems online[SDU.ASTR.HE]Sciences of the Universe [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]FísicaENERGY-SPECTRUMMonitoring programControl and monitor systems online; Large detector systems for particle and astroparticle physics; Real-time monitoringAerosolATMOSFERA (MONITORAMENTO)Air showerExperimental High Energy PhysicsFísica nuclearAstrophysics - Instrumentation and Methods for AstrophysicsAstrophysics - High Energy Astrophysical Phenomena
researchProduct

Search for supersymmetric particles in scenarios with a gravitino LSP and stau NLSP

2000

Sleptons, neutralinos and charginos were searched for in the context of scenarios where the lightest supersymmetric particle is the gravitino. It was assumed that the stau is the next-to-lightest supersymmetric particle. Data collected with the DELPHI detector at a centre-of-mass energy near 189 GeV were analysed combining the methods developed in previous searches at lower energies. No evidence for the production of these supersymmetric particles was found. Hence, limits were derived at 95% confidence level.

NEUTRALINOSParticle physicsPhysics and Astronomy (miscellaneous)LOWEST ORDER CALCULATIONSPAIR PRODUCTIONENERGIESMONTE-CARLO SIMULATIONpluridisciplinarityFOS: Physical sciences2-PHOTON PROCESSESContext (language use)01 natural sciencesLightest Supersymmetric ParticlePartícules (Física nuclear)High Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)E(+)E(-) COLLISIONS0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]RADIATIVE-CORRECTIONSontology010306 general physicsEngineering (miscellaneous)DELPHIPhysics010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyreflexivityLEPscience studiesepistemologieLARGE ELECTRON POSITRON COLLIDERhistory of sciencePARTICLE PHYSICS; LARGE ELECTRON POSITRON COLLIDER; DELPHIMONTE-CARLO SIMULATION; LOWEST ORDER CALCULATIONS; RADIATIVE-CORRECTIONS; PAIR PRODUCTION; E(+)E(-) COLLISIONS; 2-PHOTON PROCESSES; ENERGIES; BREAKING; LEP; NEUTRALINOSParticlePARTICLE PHYSICSGravitinoFísica nuclearHigh Energy Physics::ExperimentcomplexityParticle Physics - ExperimentBREAKING
researchProduct

Single intermediate vector boson production in e(+)e(-) collisions at root s=183 and 189 GeV

2001

The cross sections for the production of single charged and neutral intermediate vector bosons were measured using integrated luminosities of 52 pb-1 and 154 pb-1 collected by the experiment at centre-of-mass energies of 182.6 GeV and 188.6 GeV, respectively. The cross sections for the reactions were determined in limited kinematic regions. The results found are in agreement with the Standard Model predictions for these channels. © 2001 Elsevier Science B.V.

Nuclear and High Energy PhysicsParticle physicsLOWEST ORDER CALCULATIONSMONTE-CARLO SIMULATIONFOS: Physical sciences2-PHOTON PROCESSESKinematics01 natural sciencesPartícules (Física nuclear)Standard ModelVector bosonHigh Energy Physics - ExperimentPHYSICSHigh Energy Physics - Experiment (hep-ex)BHABHA SCATTERINGLEP20103 physical sciencesPROGRAM[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]DELPHIPhysics010304 chemical physics010308 nuclear & particles physicsCOUPLINGSLARGE ELECTRON POSITRON COLLIDERPhysique atomique et nucléaire3. Good healthMONTE-CARLO SIMULATION; LOWEST ORDER CALCULATIONS; 2-PHOTON PROCESSES; BHABHA SCATTERING; PROGRAM; DELPHI; COUPLINGS; COLLIDERS; PHYSICS; LEP2COLLIDERSPARTICLE PHYSICS; LARGE ELECTRON POSITRON COLLIDER; DELPHIPARTICLE PHYSICSProduction (computer science)High Energy Physics::ExperimentParticle Physics - Experiment
researchProduct

Measurement of the transverse spin correlation in Z → τ+ τ- decays

1997

The measurement of the correlation between the transverse spin components of tau(+)tau(-) pairs collected during 1992 to 1994 with the DELPHI detector at LEP1 is presented. A value C-TT = 0.87 +/- 0.20 (stat.)(-0.12)(+0.10) (syst.) was obtained for the correlation parameter, in agreement with the Standard Model expectation. (C) 1997 Published by Elsevier Science B.V.

QuarkNuclear and High Energy PhysicsParticle physicsLUND MONTE-CARLOElectron–positron annihilationLEP-SLC ENERGIES01 natural sciencesPartícules (Física nuclear)JET FRAGMENTATIONStandard ModelNuclear physicsPHYSICS0103 physical sciencesRADIATIVE-CORRECTIONS010306 general physicsNuclear ExperimentDetectors de radiacióLUND MONTE-CARLO; LEP-SLC ENERGIES; RADIATIVE-CORRECTIONS; JET FRAGMENTATION; TAU-POLARIZATION; SIMULATION; PHYSICS; QUARKSpin-½DELPHIPhysics010308 nuclear & particles physicsTAU-POLARIZATIONQUARKCenter (category theory)LARGE ELECTRON POSITRON COLLIDERTransverse planePARTICLE PHYSICS; LARGE ELECTRON POSITRON COLLIDER; DELPHISIMULATIONPARTICLE PHYSICSHigh Energy Physics::ExperimentAstrophysics::Earth and Planetary Astrophysics
researchProduct

Search for a fermiophobic Higgs at LEP 2

2001

Higgs bosons predicted by the fermiophobic scenario within Two Higgs Doublets Models were searched for in the data collected by the DELPHI detector at centre-of-mass energies between 189 GeV and 202 GeV, corresponding to a total integrated luminosity of 380 pb^{-1}. No signal was found and confidence limits were derived in the framework of possible extensions of the Standard Model Higgs sector.

BOSONSNuclear and High Energy PhysicsParticle physicsENERGIESQUARK PAIR PRODUCTION; CARLO PROGRAM KORALZ; MONTE-CARLO; BHABHA SCATTERING; SUPERSYMMETRY; PHOTONS; PHYSICS; BOSONS; ANNIHILATION; ENERGIESFOS: Physical sciencesPHOTONS01 natural sciencesPartícules (Física nuclear)High Energy Physics - ExperimentHiggs sectorStandard ModelPHYSICSHigh Energy Physics - Experiment (hep-ex)BHABHA SCATTERINGCARLO PROGRAM KORALZMONTE-CARLO0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]010306 general physicsANNIHILATIONSUPERSYMMETRYBosonDELPHIPhysicsLuminosity (scattering theory)010308 nuclear & particles physicsDetectorHigh Energy Physics::PhenomenologyQUARK PAIR PRODUCTIONLARGE ELECTRON POSITRON COLLIDERPARTICLE PHYSICS; LARGE ELECTRON POSITRON COLLIDER; DELPHIHiggs bosonPARTICLE PHYSICSFísica nuclearHigh Energy Physics::ExperimentParticle Physics - Experiment
researchProduct

Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study

2015

Background: Overall survival after cancer is frequently used when assessing a health care service’s performance as a whole. It is mainly used by the public, politicians and the media, and is often dismissed by clinicians because of the heterogeneous mix of different cancers, risk factors and treatment modalities. Here we give survival details for all cancers combined in Europe, correlating it with economic variables to suggest reasons for differences. Methods: We computed age and cancer site case- mix standardised relative survival for all cancers combined (ACRS) for 29 countries participating in the EUROCARE-5 project with data on more than 7.5 million cancer cases from 87 population-based…

Cancer ResearchPopulationPopulation-based cancer registrieAll cancerGross domestic productCase-mix by cancer siteCase mix indexHealth careMedicineeducationMETIS-311842education.field_of_studyRelative survivalbusiness.industryCancerCancer survivalPopulation-based cancer registriesmedicine.diseaseCancer survivalEastern europeanOncologyAll cancer ; Cancer survival ; Case-mix by cancer site ; EUROCARE ; Population-based cancer registriesbusinessEUROCAREIR-97293Demography
researchProduct

Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5

2015

Abstract Background This work presents relative survival estimates regarding urinary tract tumours among adult patients (age ⩾ 15 years) diagnosed in Europe. It reports on survival estimates of cases diagnosed in 2000–2007, and on survival time trends from 1999–2001 to 2005–2007. Methods Data on 677,340 adult urinary tract tumour patients, (429,154 cases of invasive and non-invasive bladder and 248,186 cases of invasive kidney cancers) diagnosed between 2000 and 2007 were provided by 86 population-based cancer registries from 29 European countries. The complete approach was used to estimate survival in 2000–2007; the period approach was used to estimate survival over time. Results The age-s…

Cancer Researchmedicine.medical_specialtyUrinary systemPopulationPopulation-based cancer registrieInternal medicineMedicineeducationGynecologyeducation.field_of_studyUrinary bladderRelative survivalbusiness.industryUrinary bladder tumoursCancer survival; EUROCARE; Kidney cancer; Population-based cancer registries; Urinary bladder tumoursCancerCancer survivalKidney cancermedicine.diseaseCancer survivalPopulation based studymedicine.anatomical_structureOncologybusinessKidney cancerEUROCARE
researchProduct

Measurement of the mass of the W boson using direct reconstruction at √s = 183 GeV

1999

From data corresponding to an integrated luminosity of 53.5 pb(-1) taken during the 183 GeV run in 1997, DELPHI has measured the W mass from direct reconstruction of WW --> lq (q) over bar and WW --> q (q) over bar q (q) over bar events. Combining these channels, a value of m(w) = 80.238 +/- 0.154(stat) +/- 0.035(syst) +/- 0.035(fsi) +/- 0.021 (LEP) GeV/c(2) is obtained, where fsi denotes final state interaction. Combined with the W mass obtained by DELPHI from the WW production cross-section and with the direct measurement at 172 GeV this leads to a measured value of m(w) = 80.270 +/- 0.137(stat) +/- 0.031(syst) +/- 0.030(fsi) +/- 0.021(LEP)GeV/c(2), in good agreement with the Standard Mod…

Nuclear and High Energy PhysicsParticle physicsEINSTEIN CORRELATIONSCLUSTERING-ALGORITHMElectron–positron annihilationMathematicsofComputing_GENERALCOLOR DIPOLE MODEL01 natural sciencesComputer Science::Digital LibrariesPartícules (Física nuclear)LuminosityStandard ModelPHYSICSEVENTSNuclear physicsLEP20103 physical sciencesMONTE-CARLO PROGRAM[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]ANNIHILATION010306 general physicsDELPHIPhysicsAnnihilation010308 nuclear & particles physicsE(+)E(-) INTERACTIONSTheoryofComputation_GENERALLARGE ELECTRON POSITRON COLLIDERMONTE-CARLO PROGRAM; PAIR CROSS-SECTION; COLOR DIPOLE MODEL; E(+)E(-) INTERACTIONS; EINSTEIN CORRELATIONS; CLUSTERING-ALGORITHM; ANNIHILATION; PHYSICS; EVENTS; LEP2PARTICLE PHYSICS; LARGE ELECTRON POSITRON COLLIDER; DELPHIComputer Science::Mathematical SoftwarePARTICLE PHYSICSProduction (computer science)Física nuclearPAIR CROSS-SECTIONParticle Physics - ExperimentBar (unit)
researchProduct

Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study

2015

Abstract Background We provide updated estimates of survival and survival trends of male genital tumours (prostate, testicular and penis cancers), in Europe and across European areas. Methods The complete approach was used to obtain relative survival estimates for patients diagnosed in 2000–2007, and followed up through 2008 in 29 countries. Data came from 87 cancer registries (CRs) for prostate tumours and from 86 CRs for testis and penis tumours. Relative survival time trends in 1999–2007 were estimated by the period approach. Data came from 49 CRs in 25 countries. Results We analysed 1,021,275 male genital cancer cases. Five-year relative survival was high and decreased with increasing a…

OncologyCancer Researchmedicine.medical_specialtySurvivalRelative survivalbusiness.industryCancer registrieIncidence (epidemiology)ProstateCancerPenile cancermedicine.diseaseProstate cancermedicine.anatomical_structureOncologyProstateInternal medicineCancer registries; Penile cancers; Prostate; Survival; Survival trends; TesticularSurvival trendmedicineTesticularPenile cancerbusinessPenisTesticular cancer
researchProduct

Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival esti…

2017

Abstract Background Cancer registries (CRs) are fundamental for estimating cancer burden, evaluating screening and monitoring health service performance. Stage at diagnosis—an essential information item collected by CRs—has been made available, for the first time, by CRs participating in EUROCARE-5. We analysed the quality of this information and estimated stage-specific survival across Europe for CRs with good data quality. Data and methods Sixty-two CRs sent stage (as TNM, condensed TNM or extent of disease) for 15 cancers diagnosed in 2000–2007. We assessed the quality, partly by comparing stage according to the three systems. We also developed procedures to reconstruct stage (categories…

Malemedicine.medical_specialtyCancer ResearchStage at diagnosiSurvivalConcordanceCancer registrieCancer registries ; Data quality ; Stage at diagnosis ; SurvivalSocio-culturaleReproducibility of ResultPredictive Value of TestCancer registries; Data quality; Stage at diagnosis; Survival; Data Accuracy; Europe; Female; Humans; Male; Neoplasm Metastasis; Neoplasms; Predictive Value of Tests; Reproducibility of Results; Survival Analysis; Neoplasm Staging; Registries; Oncology; Cancer Research03 medical and health sciences0302 clinical medicineBreast cancerPredictive Value of TestsNeoplasmsmedicineotorhinolaryngologic diseasesCancer registriesHumans030212 general & internal medicineRegistriesStage (cooking)Neoplasm MetastasisIntensive care medicineSurvival analysisCancer stagingNeoplasm Stagingbusiness.industryData qualityReproducibility of ResultsStage at diagnosismedicine.diseaseSurvival AnalysisCancer registryData AccuracyClinical trialNeoplasm MetastasiEuropeOncology030220 oncology & carcinogenesisData qualityNeoplasmFemaleSurvival AnalysibusinessHumanEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5

2017

Background: Incidence rates of thyroid cancer (TC) increased in several countries during the last 30 years, while mortality rates remained unchanged, raising important questions for treatment and follow-up of TC patients. This study updates population-based estimates of relative survival (RS) after TC diagnosis in Europe by sex, country, age, period and histology.Methods: Data from 87 cancer registries in 29 countries were extracted from the EUROCARE-5 dataset. One-and 5-year RS were estimated using the cohort approach for 86,690 adult TC patients diagnosed in 2000-2007 and followed-up to 12/31/2008. RS trends in 1999-2007 and 10-year RS in 2005-2007 were estimated using the period approach…

RegistrieMaleCancer ResearchIMPACTCancer registrie[SDV]Life Sciences [q-bio]Papillary0302 clinical medicineQUALITY-OF-LIFEResidence CharacteristicsAdenocarcinoma FollicularCancer registriesRegistriesThyroid cancerThyroid Neoplasmeducation.field_of_studyRelative survivalIncidence (epidemiology)Mortality rateIncidenceDiagnosis-Related GroupCancer registries; EUROCARE; Europe; Papillary; Relative survival; Thyroid cancer; Adenocarcinoma Follicular; Adolescent; Adult; Aged; Carcinoma; Carcinoma Papillary; Diagnosis-Related Groups; Europe; Female; Humans; Incidence; Male; Middle Aged; Registries; Residence Characteristics; Sex Distribution; Thyroid Neoplasms; Young Adult; Oncology; Cancer ResearchMiddle AgedPREVALENCE3. Good healthEuropeOncologyThyroid Cancer Papillary030220 oncology & carcinogenesisCohortFemaleEUROCAREHumanAdultmedicine.medical_specialtyAdolescentPopulationGEOGRAPHICAL-DISTRIBUTIONUNITED-STATESSocio-culturale030209 endocrinology & metabolismAdenocarcinomaRelative survivalThyroid cancerRECENT TRENDS03 medical and health sciencesYoung AdultMANAGEMENTmedicineHumansThyroid NeoplasmsSex DistributioneducationSurvival rateDiagnosis-Related GroupsAgedbusiness.industryMORTALITYCarcinomaFollicularCancer registries; EUROCARE; Europe; Papillary; Relative survival; Thyroid cancer; Oncology; Cancer Researchmedicine.diseaseCarcinoma PapillaryCancer registrySurgeryMICROCARCINOMAResidence CharacteristicCancer registries ; EUROCARE ; Europe ; Papillary ; Relative survival ; Thyroid cancerbusinessDemography
researchProduct

Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score

2021

The British journal of surgery 108(11), 1274-1292 (2021). doi:10.1093/bjs/znab183

Cuidado perioperatorioAcademicSubjects/MED00910Settore MED/18 - CHIRURGIA GENERALEMedizinpulmonary complicationspreoperative screeningDatasets as TopicSurgical Procedures Operative/mortality030230 surgeryperioperative care ; surgical procedures ; operative mortality ; machine learning ; sars-cov-2Medical and Health SciencesProcediments quirúrgicsCohort StudiesMachine LearningTumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14]0302 clinical medicineModelsProcedimientos quirúrgicosMedicine and Health SciencesCOVIDSurg Collaborative Co-authorsMedicine030212 general & internal medicineskin and connective tissue diseasesRapid Research Communication11 Medical and Health SciencesOperative/mortalitySARS-CoV-19COVID-19/mortalityStatisticalCOVID-19/mortality; Cohort Studies; Datasets as Topic; Humans; Machine Learning; Models Statistical; Risk Assessment; SARS-CoV-2; Surgical Procedures Operative/mortalityCOVID-19; Cohort Studies; Datasets as Topic; Humans; Machine Learning; SARS-CoV-2; Surgical Procedures Operative; Models Statistical; Risk AssessmentAprendizaje automáticoOperativeSurgical Procedures OperativeoutcomeOperativo[SDV.IB]Life Sciences [q-bio]/BioengineeringPatient SafetyAcademicSubjects/MED000106.4 SurgeryLife Sciences & BiomedicineHuman61medicine.medical_specialty616.9Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-.Risk AssessmentNOCOVIDSurg CollaborativeVaccine Related03 medical and health sciencesClinical ResearchBiodefenseCures perioperatòriesAprenentatge automàticMortalitatHumansOperatiusLS7_4Surgical ProceduresScience & TechnologyModels Statisticalbusiness.industrySARS-CoV-2SARS-CoV-2 infectionKirurgiPreventionnot indicatedcovid 19fungiEvaluation of treatments and therapeutic interventionsCOVID-19Perioperativecovid 19; pulmonary complications; postoperative mortality risk; SARS-CoV-2 infection; preoperative screening; vaccinationvaccinationmortalityGood Health and Well BeingMortalidadEmergency medicineSurgeryHuman medicineCohort Studiebusinesspostoperative mortality riskPerioperative care
researchProduct